Moderna doses first patient in study on its COVID-19 booster vaccine
By Syndicated ContentMar 15, 2021 | 9:40 AM
(Reuters) – Moderna Inc said on Monday it has dosed the first patient in an early-stage study of its COVID-19 vaccine candidate, being evaluated as a potential booster shot for previously vaccinated people.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (616) 392-3121.